{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:51Z","timestamp":1782902091142,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1136\/ard.55.10.761","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis."],"prefix":"10.1016","volume":"55","author":[{"given":"P.G","family":"Vlachoyiannopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tsifetaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Galaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A","family":"Papiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"1665","volume-title":"Harrison: Principles of internal","year":"1994","unstructured":"Gilliland BC. Systemic sclerosis (scleroderma). In: Isserbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison: Principles of internal medicine, 13th ed (international edition). New York: McGraw-Hill, 1994:1665-71."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.135.6.1351","article-title":"Connective tissue synthesis by scleroderma skin fibroblasts in cell culture","volume":"135","author":"EC, Le Roy","year":"1972","unstructured":"Le Roy EC. Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med 1972;135: 1351-62.","journal-title":"J Exp Med"},{"key":"ref_3","first-page":"921","article-title":"Scleroderma: increased biosynthesis of triplehelical type I and II procollagens associated with unaltered expression of collagenase by skin fibroblasts","volume-title":"culture. J7 Clin Invest","volume":"64","author":"Uitto, J.; Bauer, E.A.; Eisen, A.Z.","year":"1979","unstructured":"Uitto J, Bauer EA, Eisen AZ. Scleroderma: increased biosynthesis of triplehelical type I and II procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J7 Clin Invest 1979;64:921-30."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm, A.D.; Whiteside, T.L.; Medsger, T.A.; Rodnan, G.P.","year":"1984","unstructured":"Roumm AD, Whiteside TL, Medsger TA, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations. Arthritis Rheum 1984;27:645-53.","journal-title":"Arthritis Rheum"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.1780200410","article-title":"Cellular infiltrates in scleroderma skin","volume":"20","author":"Fleischmajer, R.; Perlish, J.S.; Reeves, J.R.T.","year":"1977","unstructured":"Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0167-5699(86)90067-8","article-title":"Regulation of fibroblast proliferation and collagen synthesis by cytokines","volume":"7","author":"Freundlich, B.; Bomalaski, J.S.; Neilson, E.; Jimenez, S.A.","year":"1986","unstructured":"Freundlich B, Bomalaski JS, Neilson E, Jimenez SA. Regulation of fibroblast proliferation and collagen synthesis by cytokines. Immunol Today 1986;7:303-7.","journal-title":"Immunol Today"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/j.2326-5205.1989.tb00012.x","article-title":"A strategy for determining the pathogenesis of systemic sclerosis","volume":"32","author":"EC, Le Roy; EA, Smith; MB, Kahaleh; M, Trojanowska; RM, Silver","year":"1989","unstructured":"Le Roy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis. Arthritis Rheum 1989;32:817-25.","journal-title":"Arthritis Rheum"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","article-title":"Vascular disease in progressive systemic sclerosis (scleroderma)","volume":"73","author":"Norton, W.L.; Nardo, J.M.","year":"1970","unstructured":"Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970; 73:317-24.","journal-title":"Ann Intern Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/ von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynauds phenomenon","volume":"94","author":"B, Kahaleh M.; I, Obsorn; C, Le Roy E.","year":"1981","unstructured":"Kahaleh M B, Obsorn I, Le Roy E C. Increased factor VIII\/ von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynauds phenomenon. Ann Intern Med 1981;94:482-4.","journal-title":"Ann Intern Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1084\/jem.149.6.1326","article-title":"Endothelial injury in scleroderma","volume":"149","author":"Kahaleh, M.B.; Sherer, G.K.; Le Roy, E.C.","year":"1979","unstructured":"Kahaleh MB, Sherer GK, Le Roy EC. Endothelial injury in scleroderma. J Exp Med 1979;149:1326-35.","journal-title":"J Exp Med"},{"key":"ref_11","first-page":"4167","article-title":"et alTransforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen","volume-title":"formation in vitro. Proc Natl Acad Sci","volume":"83","author":"Roberts, A.B.; Sporn, M.B.; Assoian, R.K.; Smith, J.M.; Roche, N.S.; Wakefield, L.M.","year":"1986","unstructured":"Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et alTransforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780380309","article-title":"Guidelines for clinical trials in systemic sclerosis (scleroderma)","volume":"38","author":"White, B.; Bauer, E.A.; Goldsmith, L.A.; Hochberg, M.C.; Katz, L.M.; Korn, J.H.","year":"1995","unstructured":"White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). Arthritis Rheum 1995; 38:351-60.","journal-title":"Arthritis Rheum"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/rheumatology\/26.2.113","article-title":"Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis","volume":"26","author":"Maslen, C.L.; Hall, N.D.; Woolf, A.D.; Maddison, P.J.","year":"1987","unstructured":"Maslen CL, Hall ND, Woolf AD, Maddison PJ. Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. BrJ? Rheumatol 1987;26: 113-7.","journal-title":"BrJ? Rheumatol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/31.6.375","article-title":"Further evidence of increased polymorphonuclear cell activity in patients with Raynauds phenomenon","volume":"31","author":"Law, C.S.; Sridges, A.B.; Muir, A.; Scott, N.; Bancroft, A.; Belch, J.J.F.","year":"1992","unstructured":"Law CS, Sridges AB, Muir A, Scott N, Bancroft A, Belch JJF. Further evidence of increased polymorphonuclear cell activity in patients with Raynauds phenomenon. Br J Rheumatol 1992;31:375-80.","journal-title":"Br J Rheumatol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI111480","article-title":"Selective inhibition of human diploid fibroblast collagen synthesis by interferons","volume":"74","author":"Jimenez, S.A.; Freundlich, B.; Rosenbloom, J.","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984;74: 1112-.","journal-title":"J Clin Invest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1084\/jem.162.2.516","article-title":"Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibrocast collagen production and latebut not early fibroblast proliferation","volume":"162","author":"Duncan, M.R.; Berman, B.","year":"1987","unstructured":"Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibrocast collagen production and latebut not early fibroblast proliferation. Jf Exp Med 1987; 162:516-27.","journal-title":"Jf Exp Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1016\/S0021-9258(18)45207-6","article-title":"Differential effects of gamma interferon on collagen and fibronectin gene expression","volume":"262","author":"Czaja, M.; Weier, F.R.; Eghbali, M.; Giambrone, M.; Mahboubah, I.; Zern, M.A.","year":"1987","unstructured":"Czaja M, Weier FR, Eghbali M, Giambrone M, Mahboubah I, Zern MA. Differential effects of gamma interferon on collagen and fibronectin gene expression. Jf Biol Chem 1987;262:13348-51.","journal-title":"Jf Biol Chem"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9343(89)80150-0","article-title":"Recombinant interferon gamma in the treatment of systemic sclerosis","volume":"87","author":"Kahan, A.; Amor, B.; Menkes, C.J.; Stauch, G.","year":"1989","unstructured":"Kahan A, Amor B, Menkes CJ, Stauch G. Recombinant interferon gamma in the treatment of systemic sclerosis. Am J Med 1989;87:273-7.","journal-title":"Am J Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.1992.tb11824.x","article-title":"Treatment of systemic sclerosis with yinterferon","volume":"126","author":"true","year":"1992","unstructured":"Hein R, Becr J, Hundgen M, Hunzelmann N, Meurer M, Braun-Falco 0, et al. Treatment of systemic sclerosis with yinterferon. BrJ Dermatol 1992;126:496-591.","journal-title":"BrJ Dermatol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.1780351005","article-title":"Treatment of systemic Sclerosis with recombinant interferon-y","volume":"35","author":"Freudlich, B.; Jiminez, S.A.; Steen, V.D.; Medger, J.A.; Szkolnickin, M.; Jaffe, H.S.","year":"1992","unstructured":"Freudlich B, Jiminez SA, Steen VD, Medger JA, Szkolnickin M, Jaffe HS.Treatment of systemic Sclerosis with recombinant interferon-y. Arthritis Rheum 1992;35: 1134-42.","journal-title":"Arthritis Rheum"},{"key":"ref_21","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"EC, Le Roy; C, Black; R, Fleischmajer; S, Jablonska; T, Krieg; JA, Medsger","year":"1988","unstructured":"Le Roy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger JA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. Jf Rheumatol 1988; 15:202-5.","journal-title":"Jf Rheumatol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/arrd.1986.133.1.97","article-title":"A clinical, radiologic and physiologic scoring system for the longitudinal assesment of patients with idiopathic pulmonary fibrosis","volume":"133","author":"Watters, L.C.; King, T.E.; Schwa, M.I.; WaldronJA, Stanford; RE, Cherniak; R.M.","year":"1986","unstructured":"Watters LC, King TE, Schwa MI, WaldronJA, Stanford RE, Cherniak RM. A clinical, radiologic and physiologic scoring system for the longitudinal assesment of patients with idiopathic pulmonary fibrosis. Annu Rev Respir Dis 1986;133:97-103.","journal-title":"Annu Rev Respir Dis"},{"key":"ref_23","first-page":"367","article-title":"A modified scleroderma skin scoring method. Clin Exp Rheumatol","volume":"4","author":"Kahaleh, M.B.; Sultany, G.L.; Smith, H.H.; Huffstutter, J.E.; Loadbolt, C.B.; LeRoy, E.C.","year":"1986","unstructured":"Kahaleh MB, Sultany GL, Smith HH, Huffstutter JE, Loadbolt CB, LeRoy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986;4:367-9."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-011-5444-4_4","article-title":"Protein blotting","volume-title":"of biological markers of disease","volume":"4","author":"Verheijen, R.; Salden, M.; Van Venrooij, W.T.","year":"1993","unstructured":"Verheijen R, Salden M, Van Venrooij WT. Protein blotting. In: Van Venrooij WT, Maini RN, eds. Manual of biological markers of disease. Amsterdam: Kluwer Academic Publishers, 1993;A4:1-25."},{"issue":"5","key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0076-6879(84)05048-5","article-title":"Measurement of 02 production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils","volume":"1","author":"Markert, M.; Andrews, P.C.; Babior, B.M.","year":"1984","unstructured":"Markert M, Andrews PC, Babior BM. Measurement of 02 production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 1984;1O5:358-63.","journal-title":"Methods Enzymol"},{"key":"ref_26","first-page":"654","article-title":"A multicenter trial of recombinant human interferon-gamma in patients with systematic sclerosis: effects on cutaneous fibrosis and interleukin-2 receptor levels","volume":"23","author":"Polisson, R.P.; Gilkeson, G.S.; Pyun, E.H.; Pisetsky, D.S.; Smith, E.A.; Simon, L.S.","year":"1996","unstructured":"Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS. A multicenter trial of recombinant human interferon-gamma in patients with systematic sclerosis: effects on cutaneous fibrosis and interleukin-2 receptor levels. J Rheumatol 1996;23:654-8.","journal-title":"J Rheumatol"},{"key":"ref_27","first-page":"139","article-title":"Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol","volume":"58","author":"Kahaleh, M.B.","year":"1991","unstructured":"Kahaleh MB. Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol 1991;58:139-44."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(93)70014-K","article-title":"A radical proposal for the pathogenesis of scleroderma","volume":"28","author":"Murrel, D.F.","year":"1993","unstructured":"Murrel DF. A radical proposal for the pathogenesis of scleroderma. JAm Acad Dermatol 1993;28:78-85.","journal-title":"JAm Acad Dermatol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.1780380807","article-title":"Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis","volume":"38","author":"Bruckdofer, K.R.; Hillary, J.B.; Bunce, T.; Vancheeswaran, R.; Black, C.M.","year":"1995","unstructured":"Bruckdofer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 1995;38: 1060-7.","journal-title":"Arthritis Rheum"},{"key":"ref_30","first-page":"75","article-title":"Microvasculature in systemic sclerosis. Clin Exp Rheumatol","volume":"16","author":"Carpentier, H.; Maricq, H.R.","year":"1990","unstructured":"Carpentier H, Maricq HR. Microvasculature in systemic sclerosis. Clin Exp Rheumatol 1990;16:75-92."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/art.1780241112","article-title":"Chromosomal break age and sister chromatid exchange frequencies in Scleroderma","volume":"24","author":"Sherer, G.; Jackson, B.B.; LeRoy, E.C.","year":"1981","unstructured":"Sherer G, Jackson BB, LeRoy EC. Chromosomal break age and sister chromatid exchange frequencies in Scleroderma. Arthritis Rheum 1981;24:1409-13.","journal-title":"Arthritis Rheum"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0891-5849(94)90246-1","article-title":"Reactive oxygen species, chromosome mutation and cancer: possible role of clastogenic factor in carcinogenesis","volume":"16","author":"Emmerit, I.","year":"1994","unstructured":"Emmerit I. Reactive oxygen species, chromosome mutation and cancer: possible role of clastogenic factor in carcinogenesis. Free Radic Biol Med 1994;16:99-109.","journal-title":"Free Radic Biol Med"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.12.4.461","article-title":"Induction of T-cell activation by oxidised low density lipoprotein","volume":"12","author":"Frostegard, J.; Wu, R.H.; Giscombe, R.; Holm, G.; Lefvert, A.K.; Nilsson, J.","year":"1992","unstructured":"Frostegard J, Wu RH, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidised low density lipoprotein. Arterioscler Thomb 1992;12:461-7.","journal-title":"Arterioscler Thomb"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1016\/S0021-9258(19)49695-6","article-title":"Akkenson ALJackson RL. Induction of interleukin 1 beta expression from peripheral blood monocyte-derived macrophages by 9hydroxyoctadecadienoic acid","volume":"267","author":"Ku, G.; Thomas, C.E.","year":"1992","unstructured":"Ku G, Thomas CE, Akkenson ALJackson RL. Induction of interleukin 1 beta expression from peripheral blood monocyte-derived macrophages by 9hydroxyoctadecadienoic acid.J Biol Chem 1992;267:14183-8.","journal-title":"J Biol Chem"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI114562","article-title":"Minimally modified low density lipoprotein stimulates monocyte endothelial interactions","volume":"85","author":"Berlimer, J.A.; Territo, M.C.; Sevanian, A.; Ramin, S.; Kim, J.A.; Bamshad, B.","year":"1990","unstructured":"Berlimer JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. _J Clin Invest 1990;85: 1260-6.","journal-title":"_J Clin Invest"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0006-291X(05)81563-3","article-title":"Induction of platelet derived growth factor-a gene expression in human smooth muscle cells by oxidized low density lipoproteins","volume":"186","author":"Zwijsen, R.M.L.; Japenga, S.C.; Heijen, A.M.P.; Vendenbos, R.C.; Koeman, J.H.","year":"1992","unstructured":"Zwijsen RML, Japenga SC, Heijen AMP, Vendenbos RC, Koeman JH. Induction of platelet derived growth factor-a gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem Biophys Res Commun 1992;186: 1410-6.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1016\/S0021-9258(18)48290-7","article-title":"Priming of the respiratory burst of neutrophils by diacylglycerol","volume":"262","author":"Bass, D.A.; Genard, C.; Olbranzt, P.; Wilson, J.; McCall, C.E.; McPhail, L.C.","year":"1987","unstructured":"Bass DA, Genard C, Olbranzt P, Wilson J, McCall CE, McPhail LC. Priming of the respiratory burst of neutrophils by diacylglycerol. JBiol Chem 1987;262:6643-9.","journal-title":"JBiol Chem"},{"key":"ref_38","first-page":"2069","article-title":"Activation of human polymorphonuclear neutrophil functions by interferonand tumor necrosis factors","volume":"135","author":"Shalaby, M.R.; Aggarwal, B.B.; Rinderkecht, E.; Svedersky, L.P.; Finkle, B.S.; Palladino, M.A.","year":"1985","unstructured":"Shalaby MR, Aggarwal BB, Rinderkecht E, Svedersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil functions by interferonand tumor necrosis factors. YImmunol 1985;135:2069-73.","journal-title":"YImmunol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0006-291X(85)91893-5","article-title":"Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased Km of the superoxide-generating NADPH oxidase","volume":"132","author":"A, Cassatela M.; V, DellaBianca; G, Berton; F, Rossi","year":"1985","unstructured":"Cassatela M A, DellaBianca V, Berton G, Rossi F. Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased Km of the superoxide-generating NADPH oxidase. Biochem Biophys Res Commun 1985; 132:908-14.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"The International Chronic Granulomatous Disease Cooperative Study Group. A control trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","year":"1991","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group. A control trial of interferon gamma to prevent infection in chronic granulomatous disease. N EnglJtMed 1991;324:509-16.","journal-title":"N EnglJtMed"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.55.10.761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:03:23Z","timestamp":1737439403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["S0003496724002176"],"URL":"https:\/\/doi.org\/10.1136\/ard.55.10.761","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1996,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.55.10.761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}